Arrhythmias & electrophysiology

The left atrial appendage closure by surgery-2 (LAACS-2) trial protocol rationale and design of a randomized multicenter trial investigating if left atrial appendage closure prevents stroke in patients undergoing open-heart surgery irrespective of preoperative atrial fibrillation status and stroke risk

Am Heart JPublished Randomised controlled trial

Study context

Population
Adults ≥18 years scheduled for first-time planned open-heart surgery in Denmark, Spain and Sweden, with or without prior atrial fibrillation (AF), irrespective of CHA2DS2-VASc scoreplanned
Participants
1,500 adults
Planned comparison
Concomitant left atrial appendage (LAA) closure vs standard care during open-heart surgery
Primary endpoint
Stroke, including TIA, adjudicated by 2 independent blinded neurologists
Follow-up
2 years
Methodological detailsprotocol, multicentre, stratified randomisation, 1:1, blinded outcome assessment, Sample size powered (90%, significance level 0.05) to detect a 60% relative risk reduction in the primary outcome
  • Protocol
  • Multicentre
  • Stratified randomisation
  • 1:1
  • Blinded outcome assessment
  • Sample size powered (90%, significance level 0.05) to detect a 60% relative risk reduction in the primary outcome

No results yet. This paper sets out the design of a trial; its results are to come.

Original publication

The left atrial appendage closure by surgery-2 (LAACS-2) trial protocol rationale and design of a randomized multicenter trial investigating if left atrial appendage closure prevents stroke in patients undergoing open-heart surgery irrespective of preoperative atrial fibrillation status and stroke risk. Am Heart J. Published 10 June 2023. doi:10.1016/j.ahj.2023.06.003

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.